INTERPHEX Innovations - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

INTERPHEX Innovations
Visitors found new container options, child-resistant concepts, and serialization solutions. This article contains bonus online material.


Pharmaceutical Technology
Volume 35, Issue 5, pp. 38-43


Hallie Forcino
This year's INTERPHEX show presented a wide range of packaging innovations. Many machines offered enhanced flexibility, modular design, and compatibility with single-use product paths.

Modular design enables a high-speed aseptic filling and stoppering machine to operate in intermittent or continuous motion and to accommodate various filling methods, including powder filling. It's also easy to add as many as 12 filling stations or quality-control points, such as checkweighing. Fill volumes range from 0.25 to 100 mL. The servo-controlled machine operates at 400 vials/min with 100% checkweighing, and 600 vials/min if only a sampling of containers is checkweighed (Xtrema F2000 filling and stoppering machine, IMA Life).


The Xtrema F2000 high-speed filling and stoppering machine from IMA Life has automatic feedback that adjusts the dose if fill volumes drift out of specifications.
Another highly flexible line can be aseptic or nonaseptic, handles glass or plastic bottles or vials, and can accommodate different filling systems with as many as eight filling heads. Three closing stations can be set up to handle various fittings, stoppers, and cap styles. The system also can incorporate pre- and postfilling gas flushing, empty- and full-container checkweighing with feedback loop, 100% torque measurement, inspection cameras, and labeling. On its maximum fill of 1100 mL, output can reach 120 bottles/min. Changeover takes 15 min (Kugler Linoline, Optima Group).


The touch-panel interface on Colanar's benchtop filler stores as many as 50 recipes in its memory.
A blow-fill-seal machine designed for parenteral products eliminates hydraulics and the potential for oil leaks, related particulate generation, and cleanup issues. The 21 CFR Part 11-compliant equipment fills volumes from 0.2 to 500 mL and may be built with an isolator system. Container molds include from six to 30 cavities for outputs as high as 150 containers/min. Resin choices include low-density polyethylene, high-density polyethylene, and polypropylene. An optional ultrasonic cutoff system also helps minimize particulate generation (628 Asep-Tech blow-fill-seal packaging system, Weiler Engineering).

Ionized hydrogen peroxide (H2O2) sterilizes cleanrooms and isolator interiors 50% faster than traditional spray systems. With a concentration of 7.5% versus the traditional 35%, the ionized H2O2 quickly fogs the interior of the room or enclosure; can be removed faster; and kills bacteria, viruses, mold, fungi, and spores on contact, thus achieving a six-log reduction in microorganisms. It's also less corrosive and doesn't rely on humidity to work. In operation, the H2O2 is aerosolized with house air or a compressor system and passes through a 17,000-volt electric arc to quickly fog spaces as large as 1500 ft3 (iHP 100 Mini Pod System, SixLog).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
29%
Breakthrough designations
10%
Protecting the supply chain
43%
Expedited reviews of drug submissions
10%
More stakeholder involvement
10%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here